Clinical impact of polymorphisms of transport proteins and enzymes involved in the metabolism of immunosuppressive drugs.

Full Abstract

Individualization of immunosuppressive therapy after solid organ transplantation is a goal that has been pursued for a long time. Nevertheless, in clinical practice, we are still stratifying patients in subgroups in which risk is assessed using demographic information and population analysis. Then, a combination of immunosuppressive drugs is chosen and doses are individualized to compensate for intra- and interindividual variabilities in drug pharmacokinetics, to obtain similar plasma/blood concentrations that are believed to be therapeutic, again based on data derived from population analysis. One step further in this strategy is to recognize, before initiation of immunotherapy, those patients at higher risk to be either under- or overexposed to currently used immunosuppressive drugs. Several studies have been undertaken to correlate single nucleotide polymorphisms in genes encoding transport proteins and metabolizing enzymes involved in the disposition of immunosuppressive drugs. Overall, the results from these studies have been mixed. The causes of these sometimes conflicting results include methodologic, genetic, or nongenetic factors. The degree of linkage disequilibrium, the measure of nonrandom associations between polymorphisms at different loci, not necessarily on the same chromosome, is perhaps the main genetic factor. The influence of the environment, physiology (such as kidney and liver functions), disease state, use of multidrug regimens, and inherent drug-to-drug interactions are present nongenetic factors. Moreover, it is also important to increase our knowledge of the genetic factors involved in the variabilities observed in drug responses of pharmacodynamics. True individualized therapy, with the ability to improve health outcomes of each transplant recipient, will depend on our knowledge of the genetic factors involved in immunological response and drug pharmacokinetics and pharmacodynamics.

Author information

Author/s: Rosso Felipe, C (C); de Sandes, T Veras (TV); Sampaio, E L Mandia (EL); Park, S I (SI); Silva, H Tedesco (HT); Medina Pestana, J O (JO);

Affiliation: Hospital do Rim e Hipertensão Nephrology Division, Universidade Federal de São Paulo, São Paulo, Brazil.

Journal and publication information

Publication Type: Journal Article; Review

Journal: Transplantation proceedings (Transplant Proc), published in United States. (Language: eng)

Reference: 2009-Jun; vol 41 (issue 5) : pp 1441-55

Dates: Created 2009/06/23; Completed 2009/09/28;

PMID: 19545654, status: MEDLINE (last retrieved date: 9/28/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Adrenal Cortex Hormones - metabolism; therapeutic use
Biological Transport
Carrier Proteins - genetics
Cyclosporine - metabolism; therapeutic use
Cytochrome P-450 CYP3A - genetics
Humans

Immunosuppressive Agents - metabolism; therapeutic use
Mycophenolic Acid - metabolism; therapeutic use
P-Glycoprotein - genetics; metabolism
Polymorphism, Genetic
Polymorphism, Single Nucleotide
Sirolimus - metabolism; therapeutic use

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: ABCB1 protein, human (0) ; Adrenal Cortex Hormones (0) ; Carrier Proteins (0) ; Immunosuppressive Agents (0) ; P-Glycoprotein (0) ; Mycophenolic Acid (24280-93-1) ; Sirolimus (53123-88-9) ; Cyclosporine (59865-13-3) ; CYP3A4 protein, human (EC 1.14.13.67) ; CYP3A5 protein, human (EC 1.14.14.1) ; Cytochrome P-450 CYP3A (EC 1.14.14.1)

These are the most related articles currently in our database: